The 3 analysts offering 12-month price forecasts for DiaMedica Therapeutics Inc have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 8.00. The median estimate represents a +140.64% increase from the last price of 3.74.
The current consensus among 3 polled investment analysts is to Buy stock in DiaMedica Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.29
Reporting Date Apr 29
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.